SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898430-03-002713
Filing Date
2003-05-01
Accepted
2003-04-30 20:24:02
Documents
4
Group Members
MDS HEALTH VENTURES MANAGEMENT INC.MDS LIFE SCIENCES TECHNOLOGY FUND II NC LIMITED PARTNERSHIPMDS LIFE SCIENCES TECHNOLOGY FUND IIQUEBECLIMITEDPARTNERSHIPMDS LSTF II (NCGP) INC.MDS LSTF II (QGP) INC.MICHAEL CALLAGHANMLII (NCGP) INC.MLII CO-INVESTMENT FUND

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 418443
3 SCHEDULE OF PURCHASERS TO THE SECURITIES PURCHASE AGREEMENT dex2.htm EX-2 38004
4 JOINT FILING AGREEMENT dex3.htm EX-3 34269
5 POWER OF ATTORNEY dex4.htm EX-4 40238
  Complete submission text file 0000898430-03-002713.txt   533618
Mailing Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1360 O'BRIEN DRIVE MENLO PARK CA 94025 6504625900
DEPOMED INC (Subject) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-53683 | Film No.: 03674666
SIC: 2834 Pharmaceutical Preparations

Mailing Address MDS CAPITAL CORP 100 INTERNATIONAL BLVD TORONTO ONTARIO CANA A6 0000
Business Address
MDS CAPITAL CORP (Filed by) CIK: 0001229595 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6